Skip to content

Comparison of Effectiveness of Amniotic Membrane and Duoderm Dressings in Pediatric Burns

Comparison of Effectiveness of Amniotic Membrane and Duoderm Dressings in Pediatric Burn Patients: a Randomized Controlled Trial

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04030754
Enrollment
172
Registered
2019-07-24
Start date
2018-11-01
Completion date
2020-02-14
Last updated
2020-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns

Keywords

pediatric burns, dressings, amniotic membrane, duoderm

Brief summary

There is a difference in frequency of wound infection, mean pain score, mean of time for skin grafting and hospital stay in pediatric 2nd and 3rd degree burns, between amniotic membrane and duoderm dressings

Detailed description

After informed consent of the patients, patients who will fulfill the inclusion and exclusion criteria will be enrolled in the study from Department of Pediatric Surgery, Mayo Hospital Lahore and will be randomly allocated by lottery method into 2 groups by the doctor. Group A and B with 86 patients in each group. Group A patients will be undergoing amniotic membrane dressing, while group B patients will undergo colloid gel foam dressing. Basic demographic information will be noted. Effect modifiers (hemoglobin level, weight and height) will be noted. In group A, the wounds will be washed with normal saline and then covered with amniotic membrane over which a layer of Vaseline gauze will be applied and dressing with gauze and the crape bandage will be applied. Every 3-4 days these dressings will be changed and assessed for pain, wound infection and wound c/s will be sent. Placentas from clean vaginal deliveries and elective C-sections will be taken. Blood of mother will be screened. Amniotic membrane will be separated from placenta in a clean sterile bowl. Bowl will be put in refrigerator at 4 degrees. In group B, wound will be washed with normal saline . The wound site will be covered with Colloid Gel Foam and gauze, and crape bandage will be applied. Dressing will be changed after 3-4 days. The outcome (pain score, wound infection,time for skin grafting and hospital stay) will be compared in both groups.

Interventions

COMBINATION_PRODUCTamniotic membrane

amniotic membrane is a biological dressing

COMBINATION_PRODUCTduoderm dressing

duoderm dressing is a synthetic dressing

Sponsors

King Edward Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
1 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* 10-45 % percent 2nd and 3rd degree fresh burns age less than 12 years patients of both gender

Exclusion criteria

* patients whose parents are not willing patients whose wound c/s comes positive at the time of admission patients who have associated medical disorder and trauma.

Design outcomes

Primary

MeasureTime frameDescription
mean time for skin graftingaverage time will be 21 daystime for grafting when wound has healthy granulation tissue
frequency of wound infectionat 5th day of dressingredness around burnt wound, tenderness, swelling, increased temperature (\>4 degrees), exudation and growth on wound cultures
mean of hospital stayat the time of discharge, that can be from 7th day to 30th daytime at which patient wound is completely healed and no wound infection present, average time will be up to 30 days
mean of pain for patients of age <8 years assessed by Visual Analogue Scoreat 5th day of dressing changepain will be assessed at the time of dressing change. for patients\<8 years of age visual analogue score will be used.
mean of pain for patients of age >8 years assessed by Face, Leg, Activity, Cry, Consolabilty Pain Scale.at 5th day of dressing changeFLACC (face,leg, activity, cry, consolability) pain scale will be used

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026